Watch ACHC. Know when insiders buy.
One email the day a filing lands. Free.
ACHC
Acadia Healthcare Company, Inc.
28.13
−0.25 −0.88%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
60
WATCH · shorts 60
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.6BP/E —DIV YIELD —FCF YIELD -11.25%REV TTM $3.4B +6.8%NET INCOME −$1.1B −690.1%NET DEBT $2.4B52W 11.68 – 35.61SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2026 · Mar 31 | $828.8M | +7.6% | — | — | $4.1M | −51.0% | 0.05 | $61.5M | $76.6M | −$15M | Apr 30 |
| Q4 2025 · Dec 31 | $821.5M | +6.1% | — | — | −$1.2B | −3710.4% | -12.98 | −$86.3M | $93.2M | −$179.5M | Apr 30 |
| Q3 2025 · Sep 30 | $851.6M | +4.4% | — | — | $36.2M | −46.8% | 0.40 | $73.2M | $136.2M | −$63M | Apr 30 |
| Q2 2025 · Jun 30 | $869.2M | +9.2% | — | — | $30.1M | −61.6% | 0.33 | $133.5M | $167.7M | −$34.2M | Apr 30 |
| Q1 2025 · Mar 31 | $770.5M | +0.3% | — | — | $8.4M | −89.0% | 0.09 | $11.5M | $174.6M | −$163.2M | Apr 30 |
| Q4 2024 · Dec 31 | $774.2M | +4.2% | — | — | $32.6M | −43.5% | 0.36 | $116.7M | $203.5M | −$86.8M | Feb 27 |
| Q3 2024 · Sep 30 | $815.6M | +8.7% | — | — | $68.1M | — | 0.74 | $163.1M | $190.2M | −$27.1M | Nov 5 |
| Q2 2024 · Jun 30 | $796M | +8.8% | — | — | $78.5M | +8.6% | 0.85 | $171.1M | $154.2M | $16.9M | Nov 5 |
| Q1 2024 · Mar 31 | $768.1M | — | — | — | $76.4M | — | 0.83 | −$321.3M | $142.4M | −$463.7M | Nov 5 |
| Q4 2023 · Dec 31 | $742.8M | — | — | — | $57.7M | — | 0.63 | $116.3M | $138.7M | −$22.4M | Feb 27 |
| Q3 2023 · Sep 30 | $750.3M | — | — | — | −$217.7M | — | -2.39 | $137.9M | $128.1M | $9.8M | Oct 30 |
| Q2 2023 · Jun 30 | $731.3M | — | — | — | $72.3M | — | 0.79 | $163.8M | $90.8M | $72.9M | Oct 30 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $3.3B | — | — | −$1.1B | -33.3% | -12.16 | $131.9M | $571.8M | −$439.9M | $50M | — |
| FY2024 · to Dec 31 | $3.2B | — | — | $255.6M | 8.1% | 2.78 | $129.7M | $690.4M | −$560.7M | — | — |
| FY2023 · to Dec 31 | $2.9B | — | — | −$21.7M | -0.7% | -0.24 | $462.3M | $424.1M | $38.2M | — | — |
| FY2022 · to Dec 31 | $2.6B | — | — | $273.1M | 10.5% | 2.98 | $380.6M | $296.1M | $84.4M | — | — |
| FY2021 · to Dec 31 | $2.3B | — | — | $190.6M | 8.2% | 2.10 | $374.5M | $244.8M | $129.7M | — | — |
| FY2020 · to Dec 31 | $2.1B | — | — | −$672.1M | -32.2% | -7.59 | $658.8M | $225M | $433.8M | — | — |
Every number comes from Acadia Healthcare Company, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.